Standard and Hypofractionated Dose Escalation to Intraprostatic Tumour Nodules in Localised Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Standard and hypofractionated dose escalation to intraprostatic tumour nodules in localised prostate cancer: 5 year efficacy and toxicity in the DELINEATE trial
Int. J. Radiat. Oncol. Biol. Phys 2022 Sep 20;[EPub Ahead of Print], AC Tree, L Satchwell, E Alexander, I Blasiak-Wal, N deSouza, A Gao, E Greenlay, H McNair, C Parker, J Talbot, D Dearnaley, J MurrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.